中医活血化瘀法对高血压脑梗死35例疗效研究

A study on treating 35 cases of hypertensive cerebral infarction by the activating blood and removing blood stasis method

目的:探究对临床治疗中实施中医活血化瘀法高血压脑梗死患者的效果,以及对患者血脂、血压、血黏等临床指标的影响。方法:本次研究择取70例高血压脑梗死患者参与研究,所有患者均于2016年10月-2017年10月入院,通过随机数字表法将其分为对照组与研究组,每组35例。对照组患者行常规西药阿托伐他汀胶囊治疗,研究组则在此基础上实施中医活血化瘀法(丹参川芎嗪注射液)治疗。对两组患者治疗前后血脂水平、血液黏稠度及血压水平进行对比分析,同时比较两组患者临床治疗总有效率。结果:两组患者治疗前,血脂水平、血液黏稠度及血压水平数据差异在统计学中无意义(P>0.05);经过不同方法治疗后,相比对照组,研究组患者的血脂水平、血液黏稠度及血压水平改善效果更理想,数据差异在统计学中有意义(P<0.05);治疗后,研究组患者临床治疗总有效率为(94.29%),显著高于对照组患者(74.29%),数据差异存在统计学意义(P<0.05)。结论:高血压脑梗死患者的临床治疗中实施丹参川芎嗪注射液治疗可获得优于阿托伐他汀胶囊的效果,丹参川芎嗪注射液属于活血化瘀类药物,能够有效降低患者的血脂水平和血液黏稠度,降低血管阻塞率,促进血流通常,进而缓解病情,因此该种治疗方法值得在临床中进行推广。

Objective： To explore the effect of TCM medicine on promoting blood circulation and removing blood stasis in patients with hypertensive cerebral infarction and its effect on blood lipid, blood pressure, blood viscosity and other clinical indexes. Methods： In this study, 70 patients with hypertensive cerebral infarction were selected to participate in the study. All the patients were admitted from October 2016 to October 2017. They were divided into the control group and the study group by random number table method, 35 cases in each group. The patients in the control group were treated with the routine western medicine（Atto vastatin capsule）, and the study group was treated by traditional Chinese medicine method of promoting blood circulation and removing blood stasis（Salvia miltiorrhiza Ligustrazine injection）. The levels of blood lipid, blood viscosity and blood pressure were compared between the two groups before and after treatment. Results： Before treatment, there was no significant difference in blood lipid level, blood viscosity and blood pressure between the two groups（P〈0.05）. After treatment, compared with the control group, the blood lipid level, blood viscosity and blood pressure level in the study group were improved more significantly than those in the control group, and the difference was significant in statistics（P〈0.05）. After treatment, the total treatment efficiency in the study group was 94.29%, was significantly higher than 74.29% in the control group, and the difference was statistically significant（P〈0.05）. Conclusion： In the clinical treatment of hypertension in patients with cerebral infarction, the implementation of salvia miltiorrhiza and ligustrazine injection treatment could obtain better effect than atorvastatin capsule, it belonged to drugs of promoting blood circulation to remove blood stasis, which could effectively reduce the patient＇s level of blood lipid and blood viscosity, reduced blood vessel model in addition to promoting blood flow and alleviating the symptoms, therefore, the method was worth popularizing in the clinical treatment.